Evaluating Attitudes Towards Organ Donation in the United States on MTurk

March 11, 2020 updated by: Yale-NUS College

Evaluating Attitudes Towards Organ Donation

The study is conducted to investigate the effects of priming different cultural orientations on participants' decisions on whether to donate their organs, in an opt-out donation system scenario where the default is a presumed consent on the part of the individual.

Study Overview

Detailed Description

Participants complete a survey where they respond to scales measuring their baseline cultural and power distance orientations, and answer questions on their demographics such as gender, race, employment etc.

24 hours later, participants fill in a 2nd survey where they are instructed to complete 1 out of 2 possible priming tasks. The possible tasks consist of an Individualistic priming condition and a Collectivistic priming condition; both tasks require participants to answer 3 statements each to 3 questions regarding the self or their social group. Participants then indicate their choice on whether to donate their organs (default or opt-out), rate their confidence regarding their choice and complete the same scales measuring their cultural and power distance orientations.

Study Type

Interventional

Enrollment (Actual)

211

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 138527
        • Yale-NUS College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 21 and above
  • Lives in the United States of America

Exclusion Criteria:

  • Below age 21
  • Does not live in the United States of America

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Individualistic
Participants write 3 statements to 3 questions relating to his/her differences from his/her immediate community
Participants write 3 statements each about (1) themselves, (2) why they are not like others, and (3) why it is beneficial to stand out from others
Experimental: Collectivistic
Participants write 3 statements to 3 questions relating to his/her similarities with his/her immediate community
Participants think about a social group and write 3 statements each about (1) their social group, (2) why they are like others, and (3) why it is beneficial to blend in with others

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Binary survey item - Decision to Donate Organ
Time Frame: 1 minute
From a scenario where participants imagine themselves applying for a driver's license in a country where an opt-out organ donation system is enforced, participants are asked to make a binary choice between choosing to donate their organs (default) and choosing not to donate their organs (opt out).
1 minute
Line scale survey item - Confidence in Decision to Donate Organ
Time Frame: 1 minute
Participants are asked to mark along a line scale on how confident they feel about their decision to donate their organs. The extreme ends of the line scale are defined as "Not Confident At All" (0) and "Extremely Confident" (100).
1 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Individual levels of individualism & collectivism
Time Frame: 5 minutes

Individualism and collectivism levels will be measured by Triandis & Gelfand (1998)'s "Culture Orientation Scale". This is a 16-item scale designed to measure: 1) Vertical Collectivism (VC) - seeing the self as a part of a collective and accepting hierarchy and inequality within that collective; 2) Vertical Individualism (VI) - seeing the self as fully autonomous, but recognizing and accepting the existence of inequality; 3) Horizontal Collectivism (HC) - seeing the self as part of a collective but viewing all the members of that collective as equal counterparts; and 4) Horizontal Individualism (HI) - seeing the self as fully autonomous, and believing in equality amongst individuals.

All items are answered on a 5-point scale, ranging from 1 = strongly disagree & 5 = strongly agree. Each dimension's items are summed up separately to create a VC, VI, HC, and HI score to reflect the level of collectivism and individualism in the sampled group.

5 minutes
Individual levels of power distance
Time Frame: 3 minutes

Individualism and collectivism levels will be measured by a 5-item scale used by Hanzaee and Dehkordi (2011) to measure Power Distance, defined as "the extent to which the less powerful members of institutions and organizations within a country expect and accept that power is distributed unequally" (Hofstede and Hofstede, 2005)

All items are answered on a 5-point scale, ranging from 1 = strongly disagree & 5 = strongly agree. All items are summed up to create an average score to reflect the level of power distance orientation in the sampled group.

3 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 16, 2020

Primary Completion (Actual)

February 28, 2020

Study Completion (Actual)

February 28, 2020

Study Registration Dates

First Submitted

March 11, 2020

First Submitted That Met QC Criteria

March 11, 2020

First Posted (Actual)

March 16, 2020

Study Record Updates

Last Update Posted (Actual)

March 16, 2020

Last Update Submitted That Met QC Criteria

March 11, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • HSS-1502-P02-07

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Individual Difference

Clinical Trials on Online Individualistic Prime (statement writing)

Subscribe